# | Drug | Count |
---|---|---|
0 | CISPLATIN | 3 |
1 | DOXORUBICIN | 3 |
2 | METHOTREXATE | 3 |
3 | METHOTREXATE SODIUM | 3 |
4 | IFOSFAMIDE | 2 |
5 | ADALIMUMAB | 1 |
6 | ASPARAGINASE | 1 |
7 | ASPIRIN | 1 |
8 | ASPIRIN 325 MG | 1 |
9 | ASPIRIN 81 MG | 1 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | LAROTRECTINIB | 1 | 0.0025 |
1 | ASPARAGINASE | 1 | 0.0003 |
2 | IFOSFAMIDE | 2 | 0.0002 |
3 | MERCAPTOPURINE | 1 | 0.0001 |
4 | DOXORUBICIN | 3 | 0.0001 |
5 | CISPLATIN | 3 | 0.0001 |
6 | DOXORUBICIN HYDROCHLORIDE | 1 | 0.0000 |
7 | CYTARABINE | 1 | 0.0000 |
8 | VEDOLIZUMAB | 1 | 0.0000 |
9 | TRASTUZUMAB | 1 | 0.0000 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Platinum-based Drug [EPC] | 4 | 0.0000 |
1 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
2 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
3 | Alkylating Drug [EPC] | 3 | 0.0000 |
4 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
5 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
6 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
7 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
8 | Interferon beta [EPC] | 1 | 0.0000 |
9 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |